EGFR and cervical cancer: EdU labeling analysis indicated that knockdown of FAM83B or EGFR-AS1 significantly inhibited the proliferative and migration capacity of cervical cancer cells (Figure 8A-C), indicating that EGFR-AS1 and FAM83B play an important role in maintaining malignant manifestations of cervical cancer cells.